Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 217

Sort by

Sort Order Select

Journal Articles

Routine Management, Healthcare Resource Use and Patient/Caregiver-Reported Outcomes of Patients with Transfusion-Dependent β-Thalassaemia in the United Kingdom: A Mixed Methods Observational Study

Farrukh Shah, MDMBBS,FRCPath, Paul Telfer, DM, FRCP, Mark Velangi, Shivan Pancham, Robert Wynn, Sally Pollard, Elizabeth Chalmers, Jonathan Kell, MD, Joe Hickey, PhD, Clark Paramore, MPH, Minesh Jobanputra, MD, Kate Ryan, MD

Blood (2019) 134 (Supplement_1): 3550.

https://doi.org/10.1182/blood-2019-129930

Published: 2019

Journal Articles

Neutropenia in Children Treated with Deferiprone or Deferasirox: A Report of the Largest Randomized Trial of Oral Chelators in Transfusion-Dependent Pediatric Patients

Fernando Tricta, MD, Mariagrazia Felisi, PhD, Oscar Della Pasqua, Amal El-Beshlawy, MD, Hoda Hassab, MD, Antonis Kattamis, Manika Kreka, MD, Giorgio Reggiardo, Laila Metwally Sherief, MD, Michael Spino, PharmD, Bianca Tempesta, PhD, Yu-Chung Tsang, PhD, Adriana Ceci, MD

Blood (2019) 134 (Supplement_1): 3552.

https://doi.org/10.1182/blood-2019-127933

Published: 2019

Journal Articles

Iron Chelation and Ferritin below 500 Mcg/L in Transfusion Dependent Thalassemia: Beyond the Limits of Clinical Trials

Natalia Scaramellini, MD, Carola Arighi, MD, Alessia Marcon, MD, Dario Consonni, MD, Elena Cassinerio, MD, Giovanna Graziadei, MD, Maria Domenica Cappellini, MD, Irene Motta, MD

Blood (2019) 134 (Supplement_1): 3542.

https://doi.org/10.1182/blood-2019-130237

Published: 2019

Journal Articles

Dose-Dependent Iron Chelating Effects of Eltrombopag on in Vitro Human Megakaryopoiesis

Zhi-Jian Liu, PhD, Emoke Deschmann, MD, Haley E. Ramsey, PhDMSc, Henry Feldman, Bethan Psaila, MD PhD, Nichola Cooper, MD MRCP, Evangelia Vlachodimtropoulou Koumoutsea, MBBS,PhDBSc, John B. Porter, MA MDFRCP FRCPath, James B. Bussel, MD, Michael Georgieff, MD, Martha Sola-Visner, MD

Blood (2019) 134 (Supplement_1): 2475.

https://doi.org/10.1182/blood-2019-131895

Published: 2019

Journal Articles

Randomized Controlled Trial of the Efficacy and Safety of Deferiprone in Iron-Overloaded Patients with Sickle Cell Disease or Other Anemias

Blood (2019) 134 (Supplement_1): 618.

https://doi.org/10.1182/blood-2019-122062

Published: 2019

Journal Articles

Assessment By MRI T2*of Iron Accumulation and Removal in Transfusion Dependent MDS Patients

Drorit Grizim Merkel, MD, Abraham Avigdor, MD, Arnon Nagler, MD MSc, Ohad Benjamini, MD, Yaron Davidovitz, MD, Orly Goitein, MD

Blood (2019) 134 (Supplement_1): 5432.

https://doi.org/10.1182/blood-2019-125279

Published: 2019

Journal Articles

Review of Therapeutic Erythrocytapheresis in Patients with Thalassemia Major

Erika Wall, MD, Lauren Bolster, MD

Blood (2019) 134 (Supplement_1): 1176.

https://doi.org/10.1182/blood-2019-126809

Published: 2019

Journal Articles

Effects of Luspatercept on Iron Overload and Impact on Responders to Luspatercept: Results from the BELIEVE Trial

John Porter, Maria Domenica Cappellini, MD, Thomas Coates, MD, Olivier Hermine, Vip Viprakasit, MD DPhil, Ersi Voskaridou, Hong Keng Liew, Silverio Perrotta, Abderrahim Khelif, Antonis Kattamis, Abderrahmane Laadem, Jeevan K. Shetty, Wen-Ling Kuo, Dimana Miteva, Tatiana Zinger, Peter G. Linde, Daniel Sinsimer, Ali Taher

Blood (2019) 134 (Supplement_1): 2245.

https://doi.org/10.1182/blood-2019-122561

Published: 2019

Journal Articles

Iron Chelation Improves Erythropoiesis in a Mouse Model of Myelodysplastic Syndrome

Wenbin An, MD, Maria Feola, PhD, Marc Ruiz Martinez, PhD, Amit Verma, MD, Yelena Ginzburg, MD

Blood (2018) 132 (Supplement 1): 2335.

https://doi.org/10.1182/blood-2018-99-119586

Published: 2018

Journal Articles

Decreased Iron Overload and Oxidative Stress in Transfusion Dependent Patients with Myelodysplastic Syndromes (MDS) with the Oral Iron Chelator Deferiprone

Drorit Merkel, MD, Shelly Soffer, Kalman Filanovsky, MD, Andrei Braester, MD, Eitan Fibach, PhD, Mutaz Mohammad Dana, Yishay Ofran, MD, Uri Greenbaum, MD, Arnon Nagler, MD, Moshe Mittelman, MD

Blood (2018) 132 (Supplement 1): 4381.

https://doi.org/10.1182/blood-2018-99-115157

Published: 2018

Journal Articles

A Randomized Prospective Study to Assess the Effect of Vitamin E on Peroxiredoxin- 2 As a Novel Antioxidant Marker in Young Beta-Thalassemia Major Patients on Different Chelation Therapy

Mohamed Abd el mohsen, Maha Saber, Amira Adly, Eman Ismail, Omar Elalfy, MD, Elghamry Islam, Fatma Ibrahim, Mohsen Saleh Elalfy, MD

Blood (2018) 132 (Supplement 1): 1058.

https://doi.org/10.1182/blood-2018-99-115186

Published: 2018

Journal Articles

Clinical Characterization of a Novel Mutation in SLC25A38 Resulting in Congenital Sideroblastic Anemia in a Canadian First Nations Population

Kelsey Uminski, MD BSc, Donald S. Houston, MD PhD, Jessica Hartley, MS, CGC, Geoffrey Cuvelier, MD, Sara J. Israels, MD

Blood (2018) 132 (Supplement 1): 1035.

https://doi.org/10.1182/blood-2018-99-110343

Published: 2018

Journal Articles

Isolation and Chelation Activity of Plant Phenolic Root Exudates As Potential Clinical Iron Chelators

Sarah Lane, Maia Skowron, BSc, Alixandra Wong, BSc, Kevin Yongblah, MSc, Jürgen Ehlting, MSc, PhD, Patrick B Walter, MSc, PhD

Blood (2017) 130 (Supplement 1): 3505.

https://doi.org/10.1182/blood.V130.Suppl_1.3505.3505

Published: 2017

Journal Articles

Wheatgrass Extract (Mugineic Acid): An Inexpensive and Effective Iron Chelator in Patients with Myelodysyplastic Syndromes

David P. Steensma, MD

Blood (2017) 130 (Supplement 1): 5305.

https://doi.org/10.1182/blood.V130.Suppl_1.5305.5305

Published: 2017

Journal Articles

Safety of Deferiprone in Individuals with Sickle Cell Disease

Janet L. Kwiatkowski, MD, Fernando Tricta, MD, Anna Rozova, MD

Blood (2017) 130 (Supplement 1): 2249.

https://doi.org/10.1182/blood.V130.Suppl_1.2249.2249

Published: 2017

Journal Articles

Non-Transferrin-Bound Iron Serves As Iron Source for Aspergillus Fumigatus Growth

Verena Petzer, MD, Piotr Tymoszuk, PhD, Markus Seifert, Dorothea Orth-Höller, MD, Martin Wermke, MD, Uwe Platzbecker, MD, Günter Weiss, MD, Hubertus Haas, PhD, Igor Theurl, MD PhD

Blood (2017) 130 (Supplement 1): 2214.

https://doi.org/10.1182/blood.V130.Suppl_1.2214.2214

Published: 2017

Journal Articles

Renal Function in Transfusion-Dependent β-Thalassemia Patients: A Decade of Follow-up and Comparison between Chelation Regimes

Osama Tanous, MD, Yossi Azulay, MD, Tal Dujovny, MD, Netta Schwarz, PhD, Raul Colodner, PhD, Ariel Koren, MD, Carina Levin, MDPhD

Blood (2017) 130 (Supplement 1): 949.

https://doi.org/10.1182/blood.V130.Suppl_1.949.949

Published: 2017

Journal Articles

A Systematic Review of the Effect of Iron Chelation Therapy on Survival in Patients with Sickle Cell Disease and β-Thalassemia

Samir K. Ballas, MD, Vu H. Duong, MD, Michelle Deveaux, Amer M. Zeidan, MD

Blood (2017) 130 (Supplement 1): 3743.

https://doi.org/10.1182/blood.V130.Suppl_1.3743.3743

Published: 2017

Journal Articles

Efficacy and Safety of Deferasirox in Chelation Naïve HbEβ Thalassemia Patients: Initial Experience from a Tertiary Centre of Eastern India

Debmalya Bhattacharyya, MDDM, Ranadip Chowdhury, MD, Soumita Choudhuri, Pramit Ghosh, MD, Maitreyee Bhattacharyya, DM

Blood (2017) 130 (Supplement 1): 4760.

https://doi.org/10.1182/blood.V130.Suppl_1.4760.4760

Published: 2017

Journal Articles

Impact of Treatment with Iron Chelation Therapy in Lower-Risk MDS Patients Participating in the European Leukemianet MDS (EUMDS) Registry

Blood (2017) 130 (Supplement 1): 425.

https://doi.org/10.1182/blood.V130.Suppl_1.425.425

Published: 2017

NARROW

Routine Management, Healthcare Resource Use and Patient/Caregiver-Reported Outcomes of Patients with Transfusion-Dependent β-Thalassaemia in the United Kingdom: A Mixed Methods Observational Study

Neutropenia in Children Treated with Deferiprone or Deferasirox: A Report of the Largest Randomized Trial of Oral Chelators in Transfusion-Dependent Pediatric Patients

Iron Chelation and Ferritin below 500 Mcg/L in Transfusion Dependent Thalassemia: Beyond the Limits of Clinical Trials

Dose-Dependent Iron Chelating Effects of Eltrombopag on in Vitro Human Megakaryopoiesis

Randomized Controlled Trial of the Efficacy and Safety of Deferiprone in Iron-Overloaded Patients with Sickle Cell Disease or Other Anemias

Assessment By MRI T2*of Iron Accumulation and Removal in Transfusion Dependent MDS Patients

Review of Therapeutic Erythrocytapheresis in Patients with Thalassemia Major

Effects of Luspatercept on Iron Overload and Impact on Responders to Luspatercept: Results from the BELIEVE Trial

Iron Chelation Improves Erythropoiesis in a Mouse Model of Myelodysplastic Syndrome

Decreased Iron Overload and Oxidative Stress in Transfusion Dependent Patients with Myelodysplastic Syndromes (MDS) with the Oral Iron Chelator Deferiprone

A Randomized Prospective Study to Assess the Effect of Vitamin E on Peroxiredoxin- 2 As a Novel Antioxidant Marker in Young Beta-Thalassemia Major Patients on Different Chelation Therapy

Clinical Characterization of a Novel Mutation in SLC25A38 Resulting in Congenital Sideroblastic Anemia in a Canadian First Nations Population

Isolation and Chelation Activity of Plant Phenolic Root Exudates As Potential Clinical Iron Chelators

Wheatgrass Extract (Mugineic Acid): An Inexpensive and Effective Iron Chelator in Patients with Myelodysyplastic Syndromes

Safety of Deferiprone in Individuals with Sickle Cell Disease

Non-Transferrin-Bound Iron Serves As Iron Source for Aspergillus Fumigatus Growth

Renal Function in Transfusion-Dependent β-Thalassemia Patients: A Decade of Follow-up and Comparison between Chelation Regimes

A Systematic Review of the Effect of Iron Chelation Therapy on Survival in Patients with Sickle Cell Disease and β-Thalassemia

Efficacy and Safety of Deferasirox in Chelation Naïve HbEβ Thalassemia Patients: Initial Experience from a Tertiary Centre of Eastern India

Impact of Treatment with Iron Chelation Therapy in Lower-Risk MDS Patients Participating in the European Leukemianet MDS (EUMDS) Registry

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only